TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program

Sponsor
Boston Scientific Corporation (Industry)
Overall Status
Completed
CT.gov ID
NCT00569751
Collaborator
(none)
5,016
53
45
94.6
2.1

Study Details

Study Description

Brief Summary

The TAXUS ARRIVE 2 study is a multi-center safety and surveillance study designed to to compile safety surveillance and clinical outcomes data for the TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System in routine clinical practice and to identify low frequency TAXUS related clinical events.

Condition or Disease Intervention/Treatment Phase
  • Device: TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
5016 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program
Study Start Date :
Oct 1, 2004
Actual Primary Completion Date :
Nov 1, 2006
Actual Study Completion Date :
Jul 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Rate of TAXUS stent related cardiac events as classified by the Clinical Events Committee (CEC). [1-year post-implant procedure]

Secondary Outcome Measures

  1. Rate of TAXUS stent related cardiac events as classified by the CEC. [within 30 days, 6 months and 2 years]

  2. Rate of target vessel related cardiac events as classified by the CEC. [30 days, at 6 months, at 1 and 2 years post-implant procedure]

  3. Rate of other TAXUS related events [30 days, 6 months, 1 and 2 years post-implant procedure]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Appropriate Patient Criteria:
  • Patient is eligible to receive a Boston Scientific TAXUS Stent
Inappropriate Patient Criteria:
  • Known sensitivity to paclitaxel.

  • Known allergy to stainless steel.

  • Patients in whom antiplatelet and / or anticoagulant therapy is contraindicated.

  • Patients judged to have a lesion that prevents complete inflation of an angioplasty balloon or proper placement of the stent or delivery device.

  • Patients with unresolved vessel thrombus at the lesion site.

  • Patients with coronary artery reference vessel diameters less than 2.5 mm or greater than 3.75 mm.

  • Patients with lesions located in the left main coronary artery, ostial lesions, or lesions located at a bifurcation.

  • Patients with diffuse disease or poor overflow distal to the identified lesions.

  • Patients with tortuous vessels in the region of the obstruction or proximal to the lesion.

  • Patients with a recent acute myocardial infarction where there is evidence of thrombus or poor flow.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Scottsdale Healthcare Scottsdale Arizona United States 85260
2 Bakersfield Memorial Hospital Bakersfield California United States 93301
3 Desert Cardiology Consultants Rancho Mirage California United States 92270
4 Kaiser San Francisco San Francisco California United States 94115
5 Saint Vincent's Medical Center Jacksonville Florida United States 32204
6 Health First Clinical Research Institute Melbourne Florida United States 32901
7 Cardiology Consultants Pensacola Florida United States 32504
8 The Heart and Vascular Institute of Florida St. Petersburg Florida United States 33705
9 Idaho Cardiology Associates Boise Idaho United States 83704
10 Midwest Heart Foundation Lombard Illinois United States 60148
11 Heart Care Research Foundation Merrionette Park Illinois United States 60803
12 Advocate Christ Medical Center Oak Lawn Illinois United States 60453
13 Krannert Institute of Cardiology Indianapolis Indiana United States 46202
14 The Indiana Heart Hospital Indianapolis Indiana United States 46250
15 Community Hospital Munster Indiana United States 46321
16 Iowa Heart Center Research Des Moines Iowa United States 50314
17 University of Iowa Hospitals Iowa City Iowa United States 52242
18 University of Kansas Hospital Kansas City Kansas United States 66160
19 CHRISTUS St. Frances Cabrini Hospital Alexandria Louisiana United States 71301
20 Cardiovascular Research Foundation of Louisiana Baton Rouge Louisiana United States 70808
21 Baystate Medical Center Springfield Massachusetts United States 01199
22 St. Vincent Hospital at Worcester Medical Center Worcester Massachusetts United States 01608
23 Thoracic & Cardiovascular Healthcare Foundation Lansing Michigan United States 48912
24 Great Lakes Heart and Vascular Institute St. Joseph Michigan United States 49085
25 Minnesota Heart and Vascular Center Edina Minnesota United States 55435
26 St. Paul Heart Clinic St. Paul Minnesota United States 55102
27 Barnes / Jewish (Washington University) St. Louis Missouri United States 63110
28 The Creighton Cardiac Center Omaha Nebraska United States 68131
29 Cardiovascular Associates of Delaware Valley Haddon Heights New Jersey United States 08035
30 Jersey Shore University Medical Center Neptune New Jersey United States 07754
31 New Mexico Heart Institute, PA Albuquerque New Mexico United States 87102
32 Saint Vincent's Catholic Medical Center of New York New York New York United States 10011
33 Mid-Carolina Cardiology Presbyterian Hospital Charlotte North Carolina United States 28204
34 Duke University Medical Center Durham North Carolina United States 27710
35 Bethesda North Hospital Cincinnati Ohio United States 45242
36 HeartCare, Inc Columbus Ohio United States 43215
37 Parma Community General Hospital Parma Ohio United States 44129
38 St. Vincent Mercy Medical Center Toledo Ohio United States 43608
39 Heart Center of Tulsa Tulsa Oklahoma United States 74114
40 Albert Einstein Medical Center Philadelphia Pennsylvania United States 19141
41 The Western Pennsylvania Hospital Pittsburgh Pennsylvania United States 15224
42 Moffitt Heart and Vascular Group Wormleysburg Pennsylvania United States 17043
43 Main Line Health Center Wynnewood Pennsylvania United States 19096
44 Medical University of South Carolina Charleston South Carolina United States 29403
45 Baptist Heart Institute Knoxville Tennessee United States 37920
46 St. Thomas Research Institute Nashville Tennessee United States 37205
47 Heart Center of North Texas Fort Worth Texas United States 76104
48 University of Texas Medical Branch Galveston Texas United States 77555
49 Spectra Clinical Research Management Group McAllen Texas United States 78504
50 Sentara Norfolk General Hospital Norfolk Virginia United States 23507
51 North Cascade Cardiology, PLLC Bellingham Washington United States 98225
52 Cardiology Associates of Green Bay Green Bay Wisconsin United States 54305-2425
53 South Central Wisconsin Heart Madison Wisconsin United States 53715

Sponsors and Collaborators

  • Boston Scientific Corporation

Investigators

  • Study Director: Eileen Rose, MS, Boston Scientific Corporation
  • Principal Investigator: John M Lasala, MD, PhD, Washington University School of Medicine
  • Principal Investigator: David A. Cox, MD, Lehigh Valley Physician Group

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00569751
Other Study ID Numbers:
  • S2200
First Posted:
Dec 7, 2007
Last Update Posted:
Sep 29, 2008
Last Verified:
Sep 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2008